CD Media

US Futures Soar On Report Of Positive Results From Gilead Drug

US Futures Soar On Report Of Positive Results From Gilead Drug

US equity futures are soaring after-hours following headlines from STAT news that Gilead Sciences’ experimental drug remdesivir is  “seeing rapid recoveries in fever and respiratory symptoms.”

Almost all patients were discharged in under than a week, and only two patients died, STAT said, citing comments made this week during a video discussion about trial results with University of Chicago faculty members.

STAT cautions that trials are running at other institutions and full study results can’t yet be determined; Gilead told the news outlet that it’s looking forward to data becoming available.

University of Chicago Medicine recruited 125 people into two late-stage studies, including 113 with severe Covid-19.

Gilead stocks is soaring…

To read more visit Zero Hedge.

Related posts

China Says No More Trade Talks For Now, We Can Take The Pain…This Remains To Be Seen

CD Media Staff

Fed’s Inflation Efforts ‘Likely To End Disastrously’

CD Media Staff

New Home Sales Disappoint, But Manufacturing Beats


Leave a Comment

Subscribe to our evening newsletter to stay informed during these challenging times!!